EALS is a non-profit organization on a mission to find a cure for Amyotrophic Lateral Sclerosis (ALS).
In a remarkably short period, they have established the largest and most well-structured dataset of ALS
patients globally.
This impressive feat has attracted the attention of over 11 major pharmaceutical companies with ongoing ALS drug trials.
Notably, EALS boasts the backing of leading scientific minds dedicated to research in the field of neurodegenerative diseases.
• Leading US based Non-profit organization
• Dedicated to advancing the understanding of Amyotrophic Lateral
Sclerosis (ALS)
• Mission to accelerate R&D of effective treatments for this
devastating neurological disease
• Traditional ALS testing methods were time-consuming and burdensome for patients.
• Frequent clinic visits and invasive procedures led to delayed diagnoses and limited treatment options.
• Researchers lacked real-time data to make informed decisions about patient care.
• Limited in-house technical expertise: EALS lacked a dedicated full-time tech team, hindering their development process.
• Slow development cycles: The existing development pace impeded their ability to launch clinical studies efficiently.
We addressed EALS's needs by providing a dedicated team of developers functioning as their in-house tech unit.
This solution yielded several key advantages:
• Faster development: Our dedicated team significantly accelerated the launch of web-based portals and mobile apps for clinical studies.
• Enhanced leadership: We also assumed the role of EALS's CTO, providing guidance and leadership for their development and infrastructure efforts.
• Developed user-friendly web and mobile app platforms for convenient at-home testing.
• Incorporated non-invasive testing methods to minimize patient discomfort.
• Integrated advanced analytics for accurate and timely test results.
• Convenient home testing eliminates the need for frequent clinic visits.
• Non-invasive testing methods ensure patient comfort and well-being.
• Real-time data empowers informed decision-making about care.
• Streamlined testing process for faster patient enrollment and data collection.
• Real-time access to test results facilitates informed treatment decisions.
• Improved data quality and quantity for more robust research outcomes.
EALS has experienced a transformational shift thanks to our partnership:\
• Unprecedented speed: EALS now boasts the fastest clinical study launch times within the ALS research space.
• Global leadership: They continue to hold the title for the world's largest dataset of ALS patients.
• Improved patient experience: The entire patient journey is now smoother and more hassle-free.
• Enhanced data collection: Ambassadors can now gather patient information and monitor patient adherence with greater ease.
• React Native (Mobile App Development)
• ReactJS (Web App Development)
• NodeJS (Backend Development)
• AWS (Cloud Infrastructure)
